This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
In: RESEARCH
María José Alonso’s Lab participates in the ONCOLIBERIX Consortium for the development of oncological drugs of marine origin
December 2, 2022This consortium, led by PharmaMar, brings together four leading research groups in nanotechnology and oncology.
Read More
Libera Bio receives the Bioga Award for the Best Biotech Business Idea 2020
December 11, 2020Libera Bio is a spin-off of the Maria Jose Alonso’s lab at the University of Santiago de Compostela that develops anticancer drugs based on nanotechnology. The goal of its project is to address “undruggable” oncology targets by delivering whole antibodies inside the tumor and metastatic cells.
Read More
María José Alonso receives the prestigious ‘Medal of Merit in Research and Education’ granted by the Government of Spain
July 28, 2020María José Alonso’s lab has pioneered numerous discoveries in the field of Pharmaceutical Nanotechnology and Nanomedicine. Her research is focused on designing novel nanostructured materials intended to transport drugs and antigens across biological barriers and deliver them to the target tissue, with the final goal of producing innovative nanomedicines and vaccines
Read More